Eastwood Bio-Medical Canada Inc. (TSXV:EBM)
Canada · Delayed Price · Currency is CAD 0.9700
-0.0200 (-2.02%)
Jul 31, 2026, 3:56 PM EST
TSXV:EBM Market Cap
TSXV:EBM has a market cap or net worth of CAD 66.82 million as of July 31, 2026. Its market cap has increased by 125.58% in one year.
Market Cap
66.82M
Enterprise Value
66.88M
Revenue
787.78K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.97
ChartMarket Cap Chart
Since September 19, 2014, TSXV:EBM's market cap has increased from 26.94M to 66.82M, an increase of 148.01%. That is a compound annual growth rate of 7.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 66.82M | 19.75% |
| Dec 31, 2025 | 55.80M | 50.00% |
| Dec 31, 2024 | 37.20M | -1.82% |
| Dec 6, 2023 | 37.89M | -45.00% |
| Dec 30, 2022 | 68.89M | -28.57% |
| Dec 30, 2021 | 96.44M | -30.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Helix BioPharma | 114.57M |
| ME Therapeutics Holdings | 75.12M |
| MedMira | 45.61M |
| Onco-Innovations | 44.80M |
| BriaCell Therapeutics | 44.37M |
| Sernova Biotherapeutics | 41.54M |
| Microbix Biosystems | 40.64M |
| NurExone Biologic | 40.48M |